Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease
Version 4 2024-10-20, 00:32
Version 3 2024-10-19, 23:36
Version 2 2024-06-19, 07:48
Version 1 2022-01-12, 08:31
journal contribution
posted on 2024-10-20, 00:32 authored by Morteza Abyadeh, Vivek Gupta, Veer GuptaVeer Gupta, Nitin Chitranshi, Yunqi Wu, Ardeshir Amirkhani, Anna Meyfour, Samran Sheriff, Ting Shen, Kunal DhimanKunal Dhiman, Ghasem H Salekdeh, Paul A Haynes, Stuart L Graham, Mehdi MirzaeiComparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease
History
Journal
Aging and DiseaseVolume
12Pagination
1964-1976Location
Fort Worth, Tex.Open access
- Yes
Link to full text
ISSN
2152-5250eISSN
2152-5250Language
engPublication classification
C1 Refereed article in a scholarly journalIssue
8Publisher
Buck Institute for Age ResearchUsage metrics
Categories
No categories selectedKeywords
A-BETA-PLAQUESAducanumabAlzheimer's diseaseAMYLOID PRECURSOR PROTEINASSOCIATIONCALCIUM HOMEOSTASISGAMMA AGONIST PIOGLITAZONEGeriatrics & GerontologyINFLAMMATIONLife Sciences & BiomedicineMODELNONSTEROIDAL ANTIINFLAMMATORY DRUGSPATHOLOGYPioglitazonePPAR-GAMMAScience & TechnologyZagotenemab3209 Neurosciences3214 Pharmacology and pharmaceutical sciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC